$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Abstract AI-Helper 아이콘AI-Helper

With the decoding of human genome in 2004 and the recent development in nutritional science there has been an integration of molecular biology and nutrition. As a consequenc a now word ' molecular nutrition ' has been formed and recently the word 'nutrigenomics' is coined and widely being used. The ...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

문제 정의

  • 첫 번째는 분자생물학적 인 전통적 가설에 의해 생겨난 접근방법 이다. 영양소가 특정 유전자나 단백질 의 발현에 어떠한 영향을 미치는지에 대하여 연구하기 위해 분자생물학적 도구가 사용이 되는데, 영양소가 우리 몸의 항상성에 미치는 영향에 대하여 조사함으로써 그것들의 특성을 이해하는데 목적을 두고 있는 학문이다.
  • 가속화되고 있다. 이 논문에서는 영양소와 유전자와의 관계, 리고 영양유전 체학의 개념과 최근의 연구현황에 대하여 논할 것이다.
  • 지금까지 영양유전체학에 대한 정의와 영양유전체학을 연구하기 위해 사용되는 여러 가지 실험방법들, 또 우리 몸 의 유전자가 복제, 전사, 발현되는 과정에서 각각의 단계 에 영향을 주는 영 양소에 대하여 , 그리고 영 양유전체 학이 실제로 응용되는 분야에 대하여 살펴보았다. 위 에서 언급한 부분 이 어느 정도의 실험적 결과로 보여지고 있으나 실제로 우리 가 섭취하는 대부분의 영양소들은 여러 개의 복합물질로 만 들어져 있고 들어있는 성분도 매우 작기 때문에 특정 유전자 에 이르러서 작용하기에는 매우 약한 신호전달물질이고 장 기간에 걸쳐 노출이 되어야지만 우리 몸에 영향을 줄 수 있게 된다.
본문요약 정보가 도움이 되었나요?

참고문헌 (102)

  1. Collins FS, Morgan M, Patrinos A. 2003. The human genome project: Lessons from large-scale biology. Science 300: 286-290 

  2. Frazier ME, Johnson GM, Thomassen DG, Oliver CE, Patrinos A. 2003. Realizing the potential of the genome revolution: The genomes to life program. Science 300: 290-293 

  3. Collins FS, Green ED, Guttmacher AE, Guyer MS. 2003. ?A vision for the future of genomics research. Nature 24: 835-847 

  4. Carroll SB. 2003. Genetics and the making of Homo sapiens. Nature 24: 849-857 

  5. Fransis GA, Fayard E, Picard F, Auwerx J. 2002. Nuclear receptors and the control of metabolism. Annu Rev Pltysiol 65: 261-311 

  6. Trayhurn P. 2003. Nutritional genomics - 'Nutrigenomics', British Journal of Nutrition 89: 1-2 

  7. Moon BC, Friedman JM. 1997. The molecular basis of the obese mutation in ob2J mice. Genomics 42: 152-156 

  8. Guengerich FP. 2001. Functional genomics and proteomics applied to the study of nutritional metabolism. Nutr Rev 59: 259-263 

  9. Muller M, Kersten S. 2003. Nutrigenomics: goals and strategies. Nature Genetics 4: 315-322 

  10. Trayhurn P. 1996. Northern blotting. Proceedings of the Nutrition Society 55: 583-589 

  11. Duggan DJ, Bittner M, Chen Y, Meltzer P, Trent JM. 1999. Expression profiling using cDNA microarrays. Nat Genet 21: 10-14 

  12. Hung SC, Chang CF, Ma HL, Chen TH, Low-Tone Ho L. 2004. Gene expression profiles of early adipogenesis in human mesenchymal stem cells. Gene 340: 141-150 

  13. Pandey A, Mann M. 2000. Proteomics to study genes and genomes. Nature 405: 837-846 

  14. Tyers M, Mann M. 2003. From genomics to proteomics. Nature 422: 193-197 

  15. Hannon GJ. 2002. RNA interference. Nature 418: 244-251 

  16. Dykxhoorn DM, Novina CD, Sharp PA. 2003. Killing the messenger: short RNAs that silence gene expression. Nature Reviews Molecular Cell Biology 4: 457-467 

  17. Raptis S, Dimitriadis G. 1985. Human insulin. Clin Physiol Biochem 3: 29-42 

  18. Klemcke HG, Vallet JL, Christenson RK, Pearson PL. 2001. Erythropoietin mRNA expression in pig embryos. Anim Reprod Sci 66: 93-108 

  19. Docherty K. 1996. Transgenic animals. Proceedings of the Nutrition Society 55: 613-618 

  20. Fenech M, Ferguson LR. 2001. Vitamins/minerals and genomic stability in humans. Mutat Res 475: 1-6 

  21. Chatterjee M. 2001. Vitamin D and genome stability. Mutat Res 475: 69-87 

  22. Peehl DM, Feldman D. 2004. Interaction of nuclear receptor ligands with the vitamin D signaling pathway in prostate cancer. J Steroid Biochem Mol Biol 92: 307-315 

  23. Fenech M, Aitken C, Rinaldi J. 1998. Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis 19: 1163-1171 

  24. El-Bayoumy K. 2001. The protective role of selenium on genetic damage and on cancer. Mutat Res 475: 123-139 

  25. Dreosti IE. 2001. Zinc and the gene. Mutat Res 475: 161-167 

  26. Gadhavi PL, Raine AR, Alefounder PR, Laue ED. 1990. Complete assignment of the IH NMR spectrum and secondary structure of the DNA binding domain of GAL4. FEBS Lett 276: 49-53 

  27. Pan T, Coleman JE. 1991. Sequential assignments of the IH NMR resonances of Zn (II) 2 and 113Cd (II) 2 derivatives of the DNA-binding domain of the GAL4 transcription factor reveal a novel structural motif for specific DNA recognition. Biochemistry 30: 4212-4222 

  28. Zazopoulos E, Lalli E, Stocco DM, Sassone-Corsi P. 1997. DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 390: 311-315 

  29. Das A, Rajagopalan L, Mathura VS, Rigby SJ, Mitra S, Hazra TK. 2004. Identification of a zinc finger domain in the human NEIL2 (NeHike-2) protein. J Biol Chem 279: 47132-47138 

  30. Oshika E, Liu S, Singh G, Michalopoulos GK, Shinozuka H, Katyal SL. 1998. Antagonistic effects of dexamethasone and retinoic acid on rat lung morphogenesis. Paediatr Res 43: 315-324 

  31. NiederreitherK, Subbarayan V, Dolle P, Chambon P. 1999. Embryonic retinoic acid synthesis is essential for early mouse post-implantation development. Nature Genet 21: 444-448 

  32. Underhill TM, Weston AD. 1998. Retinoids and their receptors in skeletal development. Microsc Res Tech 43: 137-155 

  33. Chambon P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J 10: 940-954 

  34. Egea PF, Rochel N, Birck C, Vachette P, Timmins PA, Moras D. 2001. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. J Mol Biol 307: 557-576 

  35. Perlmann T, Rangarajan PN, Umesono K, Evans RM. 1993. Determinants for selective RAR and TR recognition of direct repeat HREs. Genes Dev 7: 1411-1422 

  36. Hong SE, Ahn IS, Jung HS, Rayner DV, Do MS. 2004. Effect of retinoic acid on leptin, glycerol, and glucose levels in mature rat adipocytes in vitro. J Med Food 7: 320-326 

  37. Kutuzova GD, DeLuca HF. 2004. Gene expression profiles in rat intestine identify pathways for 1, 25-dihydroxyvitamin D3 stimulated calcium absorption and clarify its immunomodulatory properties. Arch Biochem Biophys 432: 152-166 

  38. Zmuda JM, Cauley JA, Ferrell RE. 2000. Molecular epidemiology of vitamin D receptor gene variants. Epidemiologic Reviews 22: 203-217 

  39. Li YC, Amling M, Pirro AE, Priemel M, Meuse J, Baron R, Delling G, Demay MB. 1998. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 139: 4391-4396 

  40. Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, Demay MB. 1999. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: Formal histomorphometric and biomechanical analyses. Endocrinology 140: 4982-4987 

  41. Van Cromphaut SJ, Dewerchin M, Hoenderop JG, Stockmans I, Van Herck E, Kato S, Bindels RJ, Collen D, Carmeliet P, Bouillon R, Carmeliet G. 2001. Duodenal calcium absorption in vitamin D receptor-knockout mice: Functional and molecular aspects. Proc Natl Amd Sci USA 98: 13324-13329 

  42. Sugiyama T, Kawai S. 2001. Carboxylation of osteocalcin may be related to bone quality: a possible mechanism of bone fracture prevention by vitamin K. J Bone Miner Metab 19: 146-149 

  43. Uitterlinden AG, Fang Y, Bergink AP, van Meurs JB, van Leeuwen HP, Pols HA. 2002. The role of vitamin D receptor gene polyrnorphisms in bone biology. Molecular and Cellular Endocrinology 197: 15-21 

  44. Jump DB. 2002 The biochemistry of n-S polyunsaturated fatty acids. Journal of Biological Chemistry 277: 8755-8758 

  45. Goodridge AG. 1987. Dietary regulation of gene expression: enzymes involved in carbohydrate and lipid metabolism. ?Annual Reviews of Nutrition 7: 157-185 

  46. Yamada K, Noguchi T. 1999. Nutrient and hormonal regulation of pyruvate kinase gene expression. Biochem J 337: 1-11 

  47. Gosiewska A, Mahmoodian F, Peterkofsky B. 1996. Gene expression of iron-related proteins during iron deficiency caused by scurvy in guinea pigs. Arch Biochem Biophys 325: 295-303 

  48. Ponka P. 1999. Cellular iron metabolism. Kidney Int Suppl 69: 2-11 

  49. Cairo G, Recalcati S, Pietrangelo A, Minotti G. 2002. The iron regulatory proteins: targets and modulators of free radical reactions and oxidative damage. Free Radic Biol Med 32: 1237-1243 

  50. Kramer G, Henderson AB, Pinphanichakarn P, Wallis MH, Hardesty B. 1977. Partial reaction of peptide initiation inhibited by phosphorylation of either initiation factor eIF-2 or 40S ribosomal proteins. Proc Natl Acad Sci USA 74: 1445-1449 

  51. Rutter GA, Leclerc I, Tsuboi T, Xavier Gda S, Diraison F, Qian Q. 2004. Imaging glucose-regulated insulin secretion and gene expression in single islet beta-cells: Control by AMP-activated protein kinase. Cell Biochem Biophys 40: 179-190 

  52. Kwok PY, Gu Z. 1999. Single nucleotide polymorphism libraries: why and how are we building them? Molecular medicine Today 5: 538-543 

  53. Nakamura Y. 1999. Impact of human genome analysis on the future medicine. Nippon Yakurigaku Zasshi 114: 126-130 

  54. Tataranni PA, Ravussin E. 1997. Effect of fat intake on energy balance. Ann N Y Acad Sci 819: 37-43 

  55. Garaulet M, Marin C, Perez-Llamas F, Canterasl M, Tebar FJ, Zamora S. 2004. Adiposity and dietary intake in cardiovascular risk in an obese population from a Mediterranean area. J Physiol Biochem 60: 39-49 

  56. Singhal A, Fewtrell M, Cole TJ, Lucas A. 2003. Low nutrient intake and early growth for later insulin resistance in adolescents born preterm. Lancet 361: 1089-1097 

  57. De Marco P, Calevo MG, Moroni A, Arata L, Merello E, Finnell RH, Zhu H, Andreussi L, Cama A, Capra V. 2002. Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet 47: 319-324 

  58. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, et al. 1995. A candidate genetic risk factor forvascular disease: a common mutation in methylenete-trahydrofolate reductase. Nat Genet 10: 111-113 

  59. van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP, Mariman EC, den Heyer M, Rozen H, Blom HJ, 1995. Mutated methylenetetrahydrofolate reductase as risk factor for spina bifida, Lancet 346: 1070-1071 

  60. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. 2001. Biological and clinical implications of the MTHFR C677T polymorphism. Trends in Pharmacological Sciences 22: 195-201 

  61. Curtin K, Bigler J, Slattery ML, Caan B, Potter JD, Ulrich CM. 2004. MTHFR C677T and A1298C polyrnorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 13: 285-292 

  62. Malloy PJ, Zhu W, Bouillon R, Feldman D. 2002. A novel nonsense mutation in the ligand binding domain of the vitamin D receptor causes hereditary 1, 25-dihydroxyvitamin D-resistant rickets. Mol Genet Metab 77: 314-318 

  63. Nejentsev S, Cooper JD, Godfrey L, Howson JM, Rance H, Nutland S, Walker NM, Guja C, Ionescu-Tirgoviste C, Savage DA, Undlien DE, Ronningen KS, Tuomilehto-Wolf E, Tuomilehto J, Gillespie KM, Ring SM, Strachan DP, Widmer B, Dunger D, Todd JA. 2004. Analysis of the vitamin D receptor gene sequence variants in type 1 diabetes. Diabetes 53: 2709-2712 

  64. Shiina T, Inoko H, Kulski JK. 2004. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 64: 631-649 

  65. Leffell MS. 2002. MHC polymorphism: Coping with the allele explosion. Clinical and Applied Immunology Reviews 3: 35-46 

  66. Guandalini S, Gupta P. 2002. Celiac disease: A diagnostic challenge with many facets. Clinical and Applied Immunology Reviews 2: 293-305 

  67. Bojkovic G, Caparevic Z, Ilic V, Stojanovic D, Lalosevic D, Stojanovic M. 2002. Case report: celiac disease. Med Pregl 55: 532-534 

  68. Morali A. 2002. Celiac disease: clinical and subclinical forms. Allerg Immunol (Paris) 34: 100-102 

  69. Stazi A V, Mantovani A. 2000. A risk factor for female fertility and pregnancy: celiac disease. Gynecol Endocrinol 14: 454-463 

  70. Lomer MC, Kodjabashia K, Hutchinson C, Greenfield SM, Thompson RP, Powell JJ. 2004. Intake of dietary iron is low in patients with Crohns disease: a case-control study. Br J Nutr 91: 141-148 

  71. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. 1999. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 20: 68-100 

  72. Kopecky J, Flachs P, Bardova K, Brauner P, Prazak T, Sponarova J. 2002. Modulation of lipid metabolism by energy status of adipocytes: implications for insulin sensitivity. Ann N Y Acad Sci 967: 88-101 

  73. Fontaine C, Dubois G, Duguay Y, Helledie T, Vu-Dac N, Gervois P, Soncin F, Mandrup S, Fruchart JC, Fruchart-Najib J. Staels B. 2003. The orphan nuclear receptor Rev-Erbalpha is a peroxisome proliferatot-activated receptor (PPAR) gamma target gene and promotes PPARgamma-induced adipocyte differentiation. J Biol Chem 278: 37672-37680 

  74. Tamori Y, Masugi J. Nishino N, Kasuga M. 2002. Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes. Diabetes 51: 2045-2055 

  75. Cowherd RM, Lyle RE, McGehee RE Jr. 1999. Molecular regulation of adipocyte differentiation. Semin Cell Dev Biol 10: 3-10 

  76. Prusty D, Park BH, Davis KE, Farmer SR. 2002. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3- L1 preadipocytes. J Biol Chem 277: 46226-46232 

  77. 조혜진, 김우식, 박소윤, 김재범. 2002. 체내 에너지 대사 조절의 중추적 기능을 담당하는 PPAR과 UCP. Biochemistry News 22: 256-265 

  78. Nadler ST, Stoehr JP, Schueler KL, Tanimoto G, Yandell BS, Attie AD. 2000. The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc Natl Acad Sci USA 97: 11371-11376 

  79. Soukas A, Cohen P, Socci ND, Friedman JM. 2000. Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev 14: 963-980 

  80. Lopez IP, Marti A, Milagro Fl, Zulet Md Mde L, Moreno-Aliaga MJ, Martinez JA, De Miguel C. 2003. DNA microarray analysis of genes differentially expressed in diet-induced (cafeteria) obese rats. Obes Res 11: 188-194 

  81. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC. 2003. PGCIalpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273 

  82. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Bema R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR, Mandarino LJ. 2003. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGCl and NRF1. Proc Natl Acad Sci USA 100: 8466-8471 

  83. Cowherd RM, Lyle RE,McGehee RE Jr. 1999. Molecular regulation of adipocyte differentiation. Semin Cell Deu Biol 10: 3-10 

  84. Ashrafi K, Chang FY, Watts JL, Fraser AG, Kamath RS, Ahringer J. Ruvkun G. 2003. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 421: 268-272 

  85. Brockmann GA, Bevova MR. 2002. Using mouse models to dissect the genetics of obesity. Trends Genet 18: 367-376 

  86. Borchardt JK. 2004. Medicinal chemistry: new technologies and developments. Drug Discov Today 9: 737-739 

  87. Challis BG, Yeo GS. 2002. Past, present and future strategies to study the genetics of body weight regulation. Brief Funct Genomic Proteomic 1: 290-304 

  88. Halvorsen YD, Wilkison WO, Briggs MR. 2000. Human adipocyte proteomics - a complementary way of looking at fat. Pharmacogenomics 1: 179-185 

  89. Chua SC Jr, Chung WK, Wu-Peng XS, Zhang Y, Uu SM, Tartaglia L, Leibel RL. 1996. Phenotypes of mouse diabetes and rat fatty due to mutations in the ob (leptin) receptor, Science 271: 994-996 

  90. Docherty K. 1996. Transgenic animals. Proceedings of the Nutrition Society 55: 613-618 

  91. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P, GuyGrand B. 1998. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392: 398-401 

  92. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. 1994. Positional cloning of the mouse obese gene and its human homolog. Nature 372: 425-432 

  93. Trayhurn P.1996. New insights into the development of obesity - obese genes and the leptin system. Proceedings of the Nutrition Society 55: 783-791 

  94. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. 1998. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 18: 213-215 

  95. Boyce RS, Duhl DM. 2004. Melanocortin-4 receptor agonists for the treatment of obesity. Curr Opin Investig Drugs 5: 1063-1071 

  96. Yiannakouris N, Melistas L, Kontogianni M, Heist K, Mantzoros CS. 2004. The Val81 missense mutation of the melanocortin 3 receptor gene, but not the 1908c/T nucleotide polymorphism in lamin NC gene, is associated with hyperleptinemia and hyperinsulinemia in obese Greek caucasians. J Endocrinol Invest 27: 714-720 

  97. Geller F, Reichwald K, Dempfle A, Illig T, Vollmert C, Herpertz S, Siffert W, Platzer M, Hess C, Gudermann T, Biebermann H, Wichmann HE, Schafer H, Hinney A, Hebebrand J 2004. Melanocortin-4 receptor gene variant 1103 is negatively associated with obesity. Am J Hum Genet 74: 572-581 

  98. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S. 1997. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387: 903-908 

  99. Martinez JA, Corbalan MS, Sanchez-Villegas A, Forga L, Marti A, Martinez-Gonzalez MA. 2003. Obesity risk is associated with carbohydrate intake in women carrying the Gln27Glu $\beta$ 2-adrenoceptor polymorphism. J Nutr 133: 2549-2554 

  100. Trayhurn P, Duncan JS, Wood AM, Beattie JH. 2000. Metallothionein gene expression and secretion in white adipose tissue. Am J Physiol Regul Integr Comp Physiol 279: 2329-2335 

  101. Adams SH. 2000. Uncoupling protein homologs: emerging views of physiological function. J Nutr 130: 711-714 

  102. De Matteis R, Arch JR, Petroni ML, Ferrari D, Cinti S, Stock MJ 2002. Immunohistochemical identification of the ${\beta}_3$ -adrenoceptor in intact human adipocytes and ventricular myocardium: effect of obesity and treatment with ephedrine and caffeine. Int J Obes Relat Metab Disord 26: 1442-1450 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로